XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of March 31, 2025
(in thousands)Level 1Level 2Level 3Total
Assets      
Money market investments (1) 
$ $6,212 $ $6,212 
Marketable equity securities (2)
901,059   901,059 
Other current investments (3)
 7,980  7,980 
Total Financial Assets
$901,059 $14,192 $ $915,251 
Liabilities
  
  
  
Contingent consideration liabilities (4)
$ $ $1,485 $1,485 
Interest rate swaps (5) 
 2,112  2,112 
Mandatorily redeemable noncontrolling interest (6)
  20,720 20,720 
Total Financial Liabilities
$ $2,112 $22,205 $24,317 

As of December 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets
  
  

  
Money market investments (1) 
$— $3,908 $— $3,908 
Marketable equity securities (2)
852,434 — — 852,434 
Other current investments (3)
— 6,309 — 6,309 
Foreign exchange swap (7)
— 710 — 710 
Total Financial Assets
$852,434 $10,927 $— $863,361 
Liabilities
  
  

  
Contingent consideration liabilities (4)
$— $— $1,419 $1,419 
Interest rate swaps (5)
— 1,419 — 1,419 
Mandatorily redeemable noncontrolling interest (6)
— — 159,548 159,548 
Total Financial Liabilities
$— $1,419 $160,967 $162,386 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. stock exchanges. Price quotes for these shares are readily available.
(3)
Includes mutual funds, which are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments.
(4)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.
(5)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
(6)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(7)Included in Other current assets and valued based on a valuation model that calculates the differential between the contract price and the market-based forward rate.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2024
$1,419 $159,548 
Changes in fair value (1)
 66,407 
Capital contributions
 80 
Accretion of value included in net income (1)
46  
Settlements or distributions
 (205,315)
Foreign currency exchange rate changes
20  
As of March 31, 2025
$1,485 $20,720 
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2023$788 $40,764 
Changes in fair value (1)
— 1,876 
Accretion of value included in net income (1)
— 
Settlements or distributions
(719)(91)
As of March 31, 2024$75 $42,549 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.